Benznidazole for chagas disease

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 4 registered trials.

Why this status

  1. 18 Jul 2019: Trial registered, NCT04024163
  2. 19 Sep 2019: Trial started, NCT04024163

The trials

NCT00699387: Population Pharmacokinetics of Benznidazole in Children With Chagas Disease

State
Completed
Phase
No phase
People
37 taking part
Started
Apr 2007
Primary completion
May 2011
Arms
Benznidazole
Results
None posted
  1. 18 Jun 2008: Trial registered

NCT03378661: BENDITA BEnznidazole New Doses Improved Treatment and Associations

State
State not given
Phase
Phase 2
People
210 taking part
Started
30 Nov 2016
Primary completion
28 Jan 2018
Arms
BZN STD Regimen, BZN 300 mg - 4 wks, BZN 300 mg - 2 wks, BZN 150 mg - 4 wks
Results
None posted
  1. 30 Nov 2016: Trial started
  2. 20 Dec 2017: Trial registered

NCT03981523: New Therapies and Biomarkers for Chagas Infection

State
Completed
Phase
Phase 2
People
450 taking part
Started
18 Dec 2019
Primary completion
29 May 2024
Arms
BZN-60, BZN-30, BZN-90
Results
None posted
  1. 11 Jun 2019: Trial registered
  2. 18 Dec 2019: Trial started
  3. 31 May 2024: Trial completed

NCT04024163: Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease

State
Under way
Phase
Phase 3
People
178 taking part
Started
19 Sep 2019
Primary completion
30 Aug 2027
Arms
Benznidazole
Results
None posted
  1. 18 Jul 2019: Trial registered
  2. 19 Sep 2019: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

About the treatment

Kind of treatment: Drug.

Also known as Radanil, Rochagan.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.